Abstract
Introduction: Being able to independently determine vaccine induced antibody responses by minimal-invasive methods is of great interest to enable a flexible and effective vaccination strategy. This study aimed to evaluate (1) the accuracy, feasibility, usability and acceptability of capillary blood and saliva self-sampling to determine SARS-CoV-2 antibody responses in patients with immune-mediated inflammatory diseases (IMIDs) and health professionals (HP).
Methods: IMID patients and HP having received two doses of SARS-CoV-2 vaccines, self-collected capillary blood (Tasso+) and saliva samples. Capillary samples were considered interchangeable with venous blood if three criteria were met: Spearman’s correlation coefficient (r) > 0.8, non-significant Wilcoxon signed-rank test (i.e., p > 0.05), and a small bias or 95% of tests within 10% difference through Bland-Altman. Participants completed a survey to investigate self-sampling usability (system usability scale; SUS) and acceptability (net promoter score; NPS). Study personnel monitored correct self-sampling completion and recorded protocol deviations.
Results: 60 participants (30 IMID patients and 30 HP) were analyzed. We observed interchangeability for capillary samples with an accuracy of 98.3/100% for Anti-SARS-CoV-2 IgG/IgA antibodies, respectively. Fifty-eight capillary blood samples and all 60 saliva samples were successfully collected within the first attempt. Usability of both self-sampling procedures was rated as excellent, with significantly higher saliva ratings ( p < 0.001). Capillary self-sampling was perceived as significantly ( p < 0.001) less painful compared to traditional venous blood collection. Participants reported a NPS for capillary and saliva self-sampling of +68% and +63%, respectively. The majority of both groups (73%) preferred capillary self-sampling over professional venous blood collection.
Conclusion: Our results indicate that capillary self-sampling is accurate, feasible and preferred over conventional venous blood collection. Implementation could enable easy access, flexible vaccination monitoring, potentially leading to a better protection of vulnerable patient groups. Self-collection of saliva is feasible and safe however more work is needed to determine its application in clinical practice.
Keywords: COVID-19; capillary blood; remote care; self-collection; self-sampling; telehealth.
【저자키워드】 COVID-19, self-collection, Self-sampling, telehealth., capillary blood, Remote care, 【초록키워드】 antibodies, Saliva, Vaccine, vaccination, protocol, feasibility, Antibody Response, SARS-CoV-2 vaccines, Health, Usability, Accuracy, Patient, capillary, Blood, Clinical practice, SARS-CoV-2 antibody response, dose, Vaccination strategy, Safe, criteria, SUS, patient groups, participant, professional, blood collection, promoter, correlation coefficient, being, Spearman, NPs, Immune-mediated inflammatory disease, effective, venous, Wilcoxon signed-rank test, flexible, analyzed, collected, evaluate, significantly, reported, majority, less, determine, significantly higher, feasible, recorded, both group, 【제목키워드】 Saliva, COVID-19 vaccine, Health, Patient, professional, Immune-mediated inflammatory disease, determine,